| (SEK) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -10.39M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, NXTCL.ST returned -3.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +50.8% |
| 1 year | -3.2% |
| 5 years | -92.3% |
| All-time high | kr 24.30 (Sep 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what kr1,000 in NXTCL.ST would be worth today ›No. NextCell Pharma AB has not paid a dividend in the past 12 months.
NextCell Pharma AB is part of the Healthcare sector.
NextCell Pharma AB has a market cap of 124.31M SEK, based on the latest quote.
